Alamar Biosciences, Inc. (ALMR) vs UFP Technologies, Inc. (UFPT)
- Alamar Biosciences, Inc. ALMR 27.45 +2.01%
- UFP Technologies, Inc. UFPT 304.28 +1.49%
Alamar Biosciences, Inc. and UFP Technologies, Inc. are both Medical Devices companies. UFP Technologies, Inc. is the larger, with a market value of $2.3B against $1.9B — 1.2× the size. Alamar Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; UFP Technologies, Inc. trades at 30.1×. UFP Technologies, Inc. has the higher net margin (11.8% vs −52.2%) and the higher return on invested capital (11.2% vs −10.1%). Across the 16 metrics below, UFP Technologies, Inc. leads on 11 and Alamar Biosciences, Inc. on 5.
Valuation
Profitability
| Metric | ALMR | UFPT | Medical Devices median |
|---|---|---|---|
| Gross margin | 58.38% | 28.95% | 57.76% |
| Operating margin | (46.53%) | 15.48% | (15.07%) |
| Net margin | (52.19%) | 11.78% | (14.45%) |
| Free cash flow margin | (104.68%) | 0.00% | (3.88%) |
| Return on equity | (64.46%) | 0.00% | (10.35%) |
| Return on assets | (20.81%) | 11.46% | (17.26%) |
| Return on invested capital | (10.07%) | 11.20% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack